SAN DIEGO--(BUSINESS WIRE)--To better support the use of highly precise, microfluidic solutions in advanced drug development, pharmaceutical and cosmetic research, Boston Micro Fabrication (BMF) proudly introduces BMF Biotechnology Inc. Headquartered in San Diego, California, BMF Biotechnology Inc. is dedicated to developing and commercializing innovative BioChips (organ-on-a-chip platforms) through cultivating large-scale tissues in vitro, helping accelerate new drug and cosmetic development..

圣地亚哥--（商业新闻短讯）--为了更好地支持高精度微流体解决方案在先进药物开发、制药和化妆品研究中的应用，波士顿微制造（BMF）骄傲地推出了BMF Biotechnology Inc.总部位于加利福尼亚州圣地亚哥，BMF Biotechnology Inc.致力于通过体外培养大规模组织来开发和商业化创新生物芯片（芯片上器官平台），帮助加速新药和化妆品的开发。。

BMF is known for its innovative and unique high precision micro-printing platforms for product designers and engineers in fields like medical device, electronics, optic/photonics and life sciences who require a high level of feature resolution and demanding dimensional tolerance. Starting in late 2022, BMF began to expand the business beyond supplying the Projection Micro Stereolithography (PµSL) platform and associated parts delivery.

BMF以其创新和独特的高精度微打印平台而闻名，该平台面向医疗器械、电子、光学/光子学和生命科学等领域的产品设计师和工程师，他们需要高水平的特征分辨率和苛刻的尺寸公差。从2022年末开始，BMF开始扩展业务，不再提供投影显微立体光刻（PµSL）平台和相关部件交付。

As part of this initiative, BMF inaugurated the San Diego Research Institute, dedicated to advancing innovative microfluidic BioChips for drug discovery and cosmetic testing. The initial phase of this endeavor has concluded with encouraging outcomes..

作为该倡议的一部分，BMF成立了圣地亚哥研究所，致力于推进用于药物发现和化妆品测试的创新微流体生物芯片。这项努力的初始阶段已经取得了令人鼓舞的成果。。

By faithfully replicating the physiological conditions found in the human body, BMF Biotechnology’s BioChips offer a powerful platform for studying health and disease biological mechanisms, evaluating drug and cosmetic safety and efficacy, and predicting patient responses. BMF BioChips feature an integrated 'vascular-mimetic' network of channels, enabling in vivo-like nutrient and waste exchange and compound delivery across the entire large tissue.

BMF生物技术公司的生物芯片通过忠实地复制人体内的生理状况，为研究健康和疾病的生物学机制、评估药物和化妆品的安全性和有效性以及预测患者反应提供了一个强大的平台。BMF生物芯片具有一个集成的“血管模拟”通道网络，可以在整个大组织中进行类似体内的营养和废物交换以及化合物输送。

This potentially yields more precise testing results and compound sensitivity compared to traditional 2D cell culture and animal models..

与传统的2D细胞培养和动物模型相比，这可能会产生更精确的测试结果和化合物敏感性。。

Robust tissue models, such as tumor models for assessing drug efficacy, kidney models for evaluating drug safety, and skin models for cosmetic assessments have been consistently cultivated. Additionally, collaborations with global partners have led to the development of various other tissue models to help researchers better understand the biological mechanisms of health and disease, including liver and heart conditions, lung cancer, endometrial cancer, and more..

稳健的组织模型，例如用于评估药物功效的肿瘤模型，用于评估药物安全性的肾脏模型以及用于美容评估的皮肤模型已经得到了一致的培养。此外，与全球合作伙伴的合作导致了各种其他组织模型的发展，以帮助研究人员更好地了解健康和疾病的生物学机制，包括肝脏和心脏病，肺癌，子宫内膜癌等。。

'Building on success that BMF has had with other self-driven innovations such as the UltraThineer veneers, the launch of BMF Biotechnology Inc. represents a significant leap forward in our ability to harness the potential of 3D BioChip technology,' remarked Dr. Jennifer Sun, Chief Scientific Officer of BMF Biotechnology Inc.

BMF Biotechnology Inc.首席科学官詹妮弗·孙博士（Dr.Jennifer Sun）表示，BMF生物技术公司（BMF Biotechnology Inc.）的推出标志着我们利用3D生物芯片技术潜力的能力取得了重大飞跃，这是BMF在超薄薄贴面等其他自主创新方面取得的成功。

'With our innovative technology and approach, we aim to empower researchers with the tools they need to translate scientific discoveries into tangible therapeutic solutions that improve patient outcomes.'.

“通过我们创新的技术和方法，我们旨在为研究人员提供所需的工具，将科学发现转化为改善患者预后的有形治疗方案。”。

To help fully realize the power of the BioChips, BMF Biotechnology is now recruiting collaboration Partners. The BMF Biotechnology Inc. Partner Program offers a range of activities for BMF Biotechnology Inc. and Partners to jointly develop and validate innovative devices and biological models. We welcome industry, research, and academic entities to reach out and explore potential collaborations with us..

为了帮助充分发挥生物芯片的力量，BMF生物技术公司目前正在招募合作伙伴。BMF Biotechnology Inc.合作伙伴计划为BMF Biotechnology Inc.和合作伙伴提供一系列活动，共同开发和验证创新设备和生物模型。我们欢迎行业、研究和学术实体与我们联系并探索潜在的合作。。

More information about BMF Biotechnology Inc. and our Partner Program can be found at www.bmfbio.com. You can also find us at the MPS World Summit 2024 in booth #9, taking place in Seattle, Wash. from June 10-14, 2024.

有关BMF Biotechnology Inc.和我们合作伙伴计划的更多信息，请访问www.bmfbio.com。您也可以在2024年6月10日至14日于华盛顿州西雅图举行的2024年MPS世界峰会第9号展位上找到我们。

About Boston Micro Fabrication

关于波士顿微制造

Boston Micro Fabrication (BMF) enables highly precise, micro-scale 3D printing across healthcare, the life sciences, electronics, and machining industries. Using the company’s proprietary PμSL (Projection Micro Stereolithography) technology, the microArch system printers produce the industry’s most accurate and precise high-resolution 3D prints for product development, research, and industrial short run production.

波士顿微制造（BMF）能够在医疗保健、生命科学、电子和机械加工行业实现高精度、微型3D打印。Microach系统打印机使用公司专有的PμSL（投影显微立体光刻）技术，为产品开发、研究和工业短期生产生产生产业界最准确和精确的高分辨率3D打印。

Founded in 2016, BMF has offices in Boston, Shenzhen, Chongqing and Tokyo with a research and development center in San Diego. For more information on BMF please visit www.bmf3d.com or follow the company on LinkedIn..

BMF成立于2016年，在波士顿、深圳、重庆和东京设有办事处，在圣地亚哥设有研发中心。有关BMF的更多信息，请访问www.bmf3d.com或在LinkedIn上关注该公司。。